Colorectal cancer screening in France: Progress report and prospects;Mise en place du dépistage du cancer colorectal en France: État d'avancement et perspectives

Hepato-Gastro

Volumn 15, Issue SPEC. ISS. SEPT., 2008, Pages 8-13

  Viguier, Jérôme ^a,b  

^a SERVICE DE DERMATOLOGIE   (France)

^b INSTITUT NATIONAL DU CANCER   (France)

Author keywords

Colorectal cancer; Guaiac; Screening

Indexed keywords

AGE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC VALUE; FRANCE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; OCCULT BLOOD; PATIENT PARTICIPATION; PRACTICE GUIDELINE; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; SIGMOIDOSCOPY; STANDARDIZATION;

EID: 53649108962     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: 10.1684/hpg.2008.0239     Document Type: Short Survey

References (25)

1. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004 ; 126 : 1674-80.
2. Lepage C, Remontet L, Launoy G, Trétarre B, Grosclaude P, Colonna M, et al. French network of cancer registries (FRANCIM).Trends in incidence of digestive cancers in France. Eur J Cancer Prev 2008 ; 17 : 13-7.
3. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007 ; 56 : 210-4.
4. Van Rossum LG, Van Rijn AF, Laheij RJ, Van Oijen MG, Fockens P, Van Krieken HH, et al. Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening Population. Gastroenterology 2008 ; [Epub ahead of print].
5. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005 ; 129 : 422-8.
6. Sun L, Wu H, Guan YS. Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging. World J Gastroenterol 2008 ; 14 : 853-63.
7. White TJ, Avery GR, Kennan N, Syed AM, Hartley JE, Monson J-R. Virtual colonoscopy versus conventional colonoscopy in patients at high risk of colorectal cancer- a prospective trial of 150 patients. Colorectal Dis 2008 ; [Epub ahead of print].
8. Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003 ; 349 : 2191-200.
9. Mulhall BP, Veerappan GR, Jackson J-L. Meta-analysis : computed tomographic colonography. Ann Intern Med 2005 ; 142 : 635-50.
10. Kim DH, Pickhart PJ, Taylor AJ, Leung WK, Winter TC, Hinshaw JL, et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 2007 ; 357 : 1403-12.
11. Schoofs N, Deviere J, van Gossum A. PillCam colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis : a prospective study. Endoscopy 2006 ; 38 : 971-7.
12. Hassan C, Zullo A, Winn S, Morini S. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer. Endoscopy 2008 ; 40 : 414-21.
13. Nakamura T, Terano A. Capsule endoscopy: past, present, and future. J Gastroenterol 2008 ; 43 : 93-9.
14. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME, Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004 ; 351 : 2704-14.
15. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC, Sontag S, et al. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007 ; 5 : 111-7.
16. Han M, Liew CT, Zhang HW, Chao S, Zheng R, Yip KT, et al. Novel blood-based, five-gene biomarker set for the detection of colorectal cancer. Clin Cancer Res 2008 ; 14 : 455-60.
17. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008 ; 54 : 414-23.
18. Tytherleigh MG, Ng VV, Mathew LO, Banerjee T, Menon KV, Mee AS, et al. Colonoscopy for screening and follow up of patients with a family history of colorectal cancer. Colorectal Dis 2008 ; 10 : 506-11.
19. Rösch T, Adler A, Pohl H, Wettschureck E, Koch M, Wiedenmann B, et al. A motor-driven single-use colonoscope controlled with a hand-held device : a feasibility study in volunteers. Gastrointest Endosc 2008 ; (accepted online).
20. Rex DK, Eid E. Considerations regarding the present and future roles of colonoscopy in colorectal cancer prevention. Clin Gastroenterol Hepatol 2008 ; 6 : 500-14.
21. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors : a population-based analysis. Gastroenterology 2007 ; 132 : 96-102.
22. Van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy : a systematic review. Am J Gastroenterol 2006 ; 101 : 343-50.
23. Niv Y, Hazazi R, Levi Z, Fraser G. Screening colonoscopy for colorectal cancer in asymptomatic people : a meta-analysis. Dig Dis Sci 2008 ; (accepted online).
24. Rundle AG, Lebwohl B, Vogel R, Levine S, Neugut AI. Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years. Gastroenterology 2008 ; 134 : 1311-5.
25. Mandel SJ. Screening for colorectal cancer. Gastroenterol Clin N Am 2008 ; 37 : 97-115.